Acceleron Pharma Stock Price - XLRN

86.57
0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Acceleron Pharma Inc XLRN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.79 -0.9% 86.57 81.78 90.59 85.53 87.36 20:00:00
Bid Price Ask Price Spread Spread % News
83.38 102.00 18.62 18.25% 3 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,803 546,163 $ 87.88 $ 47,997,322 876,939 37.01 - 95.95
Last Trade Time Type Quantity Stock Price Currency
18:50:11 1 $ 86.57 USD

Acceleron Pharma Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.60B 53.08M $ -118.87M -2.59 - 52.14M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Acceleron Pharma News

Loading Messages....

Latest XLRN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical XLRN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week94.1495.20581.7890.92341,278-7.57-8.04%
1 Month78.6995.9578.1091.59507,4577.8810.01%
3 Months49.0795.9546.0071.54592,39637.5076.42%
6 Months44.9595.9537.6060.50438,12741.6292.59%
1 Year44.6795.9537.0153.48372,33941.9093.8%
3 Years24.9195.9524.3744.38380,81961.66247.53%
5 Years40.8295.9520.0040.20342,47345.75112.08%

Acceleron Pharma Description

Acceleron Pharma is a biotechnology company focused on the discovery, development, and commercialization of novel therapies. The company's research focuses on key natural regulators of cellular growth and repair. Acceleron generates its revenue through collaboration, licensing, and research arrangements with collaboration partners for the development and commercialization of therapeutic candidates. The company sometimes uses contract research organizations and research institutions outside the United States.


Your Recent History
NASDAQ
XLRN
Acceleron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.